Showing results (91-100 of 153) with videos related to
Sort By:
Pageof 16
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 10, 1999
Incidence of Lyme borreliosis in the Würzburg region of GermanyH I Huppertz, M Böhme, S M Standaert, et al.The Journal of Infectious Diseases|May 21, 1998
Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policyA Strady, J Lang, M Lienard, et al.Surgery|August 1, 1979
Successful islet transplantation in spontaneous diabetesA Naji, W K Silvers, S A Plotkin, et al.Differentiation; Research in Biological Diversity|January 1, 1986
Differentiation of TERA-2 human embryonal carcinoma cells into neurons and HCMV permissive cells. Induction by agents other than retinoic acidP W Andrews, E Gönczöl, S A Plotkin, et al.American Journal of Diseases of Children (1960)|January 1, 1984
Vancomycin dosage in pediatrics reconsideredG Alpert, J M Campos, M C Harris, et al.Behring Institute Mitteilungen|July 1, 1984
The importance of immunologic factors in the pathogenesis of encephalomyocarditis virus induced diabetes in miceD C Dafoe, C L Moore, S A Plotkin, et al.Pediatric Infectious Disease|November 1, 1985
Diverse serologic response to rotavirus infection of infants in a single epidemicH F Clark, K T Dolan, P Horton-Slight, et al.Journal of Virology|May 1, 1991
Differentiation of human embryonal carcinoma cells induces human immunodeficiency virus permissiveness which is stimulated by human cytomegalovirus coinfectionG Hirka, K Prakash, H Kawashima, et al.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|February 1, 1984
HCMV envelope antigens induce both humoral and cellular immunity in guinea pigsT Furukawa, E Gonczol, S Starr, et al.Journal of Adolescent Health Care : Official Publication of the Society for Adolescent Medicine|April 1, 1984
Intranasal administration of RA 27/3 rubella virus vaccine. A clinical trial in young adultsJ E Paradise, D Nemorofsky, G R Huggins, et al.Pageof 16